Catalyst Wire Dossier Catalyst Wire Dossier

CD34+ Selected Stem Cell

CD34+ selected autologous hematopoietic stem cells · NYU Langone Health
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD34+ Selected Stem Cell, covering 2025-09-29 to 2025-09-29. Get the full timeline:

Most recent: Clinical Trial Update: CD34+ Selected Stem Cell for Poor Graft Function or Graft Failure [NA]

See pricing